Proteoglycans

Proteoglycans are complex extracellular macromolecules consisting of a multidomain core protein to which are attached one or more glycosaminoglycan (GAG) chains. They are structurally very diverse, due to variations in length and sequence of the core proteins as well as abundance, distribution and composition of the GAG chains. Core proteins are often arranged in modules which have structural and functional significance, and the same module may be found in more than one core protein type. A single core protein type may have different GAG substituents and differing roles in different tissues. Proteoglycans have diverse, but often vital functions in a variety of tissue context. Genetic studies of proteoglycan core proteins and their modifying enzymes have elucidated numerous heritable diseases and syndromes. Much of our understanding of the structure, function, evolution, gene regulation and mutations causing heritable disorders of proteoglycans, in general, derives from the model proteoglycan, aggrecan.

Key Concepts

  • Glycosaminoglycans are linked to proteoglycan core proteins via a limited number of O- or N-glycosyl bonds.
  • Synthesis of GAG chains proceeds by the sequential action of glycosyltransferases that catalyse transfer of a glycosyl unit from a nucleotide sugar to a protein or nonreducing end of a sugar acceptor.
  • Proteoglycans are abundant components of the extracellular matrix and associated with the cell surface.
  • Although there are only six major classes of proteoglycan types, there is great diversity in structure, size and composition.
  • Important functions have been attributed to both the protein backbone and glycosaminoglycan substituents.
  • Proteoglycans modulate numerous molecular interactions, for example, cell–cell signalling.
  • Heritable proteoglycan disorders cause a wide range of phenotypes with examples from all clinical specialities.

Keywords: glycosaminoglycans; glycosyltransferases; aggrecan; extracellular matrix; chondrodystrophies

Figure 1. Definition of a proteoglycan; cDNA domain structure and proteoglycan structure are shown.
Figure 2. Major repeat units of glycosaminoglycan chains.
close
 References
    Bernfield M, Gotte M, Park PW et al. (1999) Functions of cell surface heparan sulfate proteoglycans. Annual Review of Biochemistry 68: 729–777.
    Bishop JR, Schuksz M and Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446: 1030–1037.
    Bülow HE and Hobert O (2006) The molecular diversity of glycosaminoglycans shapes animal development. Annual Review of Cell and Developmental Biology 22: 375–407.
    Domowicz MS, Pirok EW, Novak TE and Schwartz NB (2000) Role of the C-terminal G3 domain in sorting and secretion of aggrecan core protein and ubiquitin-mediated degradation of accumulated mutant precursors. Journal of Biological Chemistry 275: 35098–35105.
    Häcker U, Nybakken K and Perrimon N (2005) Heparan sulphate proteoglycans: the sweet side of development. Nature Review of Molecular and Cellular Biology 6: 530–541.
    Herman T and Horvitz HR (1999) Three proteins involved in Caenorhabditis elegans vulval invagination are similar to components of a glycosylation pathway. Proceedings of the National Academy of Scienes of the USA 96: 974–979.
    Hildebrand A, Romaris M, Rasmussen LM et al. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with TGF . Biochemical Journal 302: 527–534.
    Immergluck LC, Domowicz M, Schwartz NB and Herold BC (1998) Viral and cellular requirements for entry of HSV-1 into primary neuronal cells. Journal of General Virology 79: 549–559.
    Kurima K, Warman ML, Krishnan S et al. (1998) A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proceedings of the National Academy of Sciences of the USA 95: 8681–8685.
    Li H and Schwartz NB (1995) Gene structure of chick cartilage CSPG (aggrecan) core protein. Journal of Molecular Evolution 41: 878–885.
    Mjaatvedt CH, Yamamura H, Capehart AA, Turner D and Markwald RR (1998) The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Developmental Biology 202: 56–66.
    Pirok EW III, Li H, Mensch JR Jr, Henry J and Schwartz NB (1997) Structural and functional analysis of the chick CSPG (aggrecan) promoter and enhancer region. Journal of Biological Chemistry 272: 11566–11574.
    Pirok EW III, Henry J and Schwartz NB (2001) Cis elements that control the expression of chick aggrecan. Journal of Biological Chemistry 276: 16894–16903.
    Pirok EW III, Domowicz MS, Henry J et al. (2005) APBP-1, a DNA/RNA-binding protein, interacts with the chick aggrecan regulatory region. Journal of Biological Chemistry 280: 35606–35616.
    Quentin E, Gladen A, Rodén L and Kresse H (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proceedings of the National Academy of Sciences of the USA 87: 1342–1346.
    Rahmani M, Wong BW, Ang L et al. (2006) Versican: signaling to transcriptional control pathways. Canadian Journal of Physiology and Pharmacology 84: 77–92. Review.
    Ruoslahti E and Yamaguchi Y (1991) Proteoglycans as modulators of growth factor activities. Cell 94: 867–869.
    Schwartz NB (2000) Biosynthesis and regulation of expression of proteoglycans. Frontiers in Bioscience 5: 649–655.
    Schwartz NB (2002a) PAPS synthetase. Encyclopedia of Molecular Medicine Journal 5: 284–287. Wiley.
    book Schwartz NB (2002b) "Carbohydrate metabolism: special pathways and glycoconjugates". In: Devlin TM (ed.), Textbook of Biochemistry, 5th edn, pp. 665–692. New York: Wiley-Liss.
    book Schwartz NB (2005) "PAPS & Sulfoconjugation". In: Human Cytosolic Sulfotranferases, pp. 43–57. London: Taylor Franscis.
    book Schwartz NB and Domowicz M (1998) "Proteoglycan gene mutations and impaired skeletal development". In: Buckwater JA, Ehrlich MG, Sandell LJ and Trippel SB (eds), Skeletal Morphogenesis and Growth, pp. 413–433. Rosemont, IL: AAOS Publications.
    Schwartz NB and Domowicz MS (2002) Chondrodysplasias due to proteoglycan defects. Glycobiology 12(4): 57R–68R.
    Schwartz NB and Domowicz MS (2004) Chondrodysplasias. Encyclopedia of Endocrine Diseases 1: 502–509. Publisher Elsevier, Inc.
    Schwartz NB, Pirok EW, Mensch JR and Domowicz MS (1999) Domain organization, genomic structure, evolution and regulation of expression of the aggrecan gene family. Progress in Nucleic Acid Research and Molecular Biology 62: 171–226.
    Song HH, Shi W, Xiang YY and Filmus J (2005) The loss of glypican-3 induces alterations in Wnt signaling. Journal of Biological Chemistry 280: 2116–2125.
    Stickens D, Clines G, Burbee D et al. (1996) The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nature Genetics 14: 25–32.
    Yamaguchi Y (2000) Lecticans: organizers of the brain extracelluar matrix. Cellular and Molecular Life Sciences 57: 276–289.
 Further Reading
    Cortes M, Baria AT and Schwartz NB (2009) Sulfation of chondroitin sulfate proteoglycans is necessary for proper Indian hedgehog signaling in the developing growth plate. Development 136: 1697–1706.
    Domowicz M, Cortes M and Schwartz NB (2009) Aggrecan modulation of growth plate morphogenesis. Developmental Biology 329: 242–257.
    Domowicz M, Sanders T, Ragsdale C and Schwartz NB (2008) Aggrecan is expressed by embryonic brain glia and regulates astrocyte development. Developmental Biology 315: 114–124.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Schwartz, Nancy B(Sep 2009) Proteoglycans. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0000623.pub2]